Imagine The End of Viruses as We Know Them

This world-first drug class irreversibly inactivates highly infectious pandemic viruses. Maxwell's novel and patented anti-infectives have been tested against a broad spectrum of viruses by independent labs - including The National Institute of Infectious Disease (Japan's CDC), Stanford, NYU and many others. These preclinical lab tests show that Maxwell's peptoid drug class is safe in cultured human lung cells, in live mouse lungs and are rapidly effective at low doses. The preclinical safety data and the irreversible nature of the treatment make Maxwell’s drug class a potentially game-changing therapeutic.
 

Urgent Need: A Safe, Effective Treatment

Maxwell's novel, patented drug class (called "Peptoids") is a functional mimic of the naturally antiviral molecule used by all human white blood cells to attack viruses - Human Cathelicidin Antimicrobial Peptide, or more simply labeled as "LL-37." For over 200 million years, LL-37 has successfully defended mammals against viruses without allowing viruses to develop significant resistance. Maxwell's peptoids mimic LL-37's magnetic properties, allowing peptoids to bind to the structure of viruses and irreversibly inactivate them - the biological equivalent of injecting a sticky glue into the internal gears of a complex machine. [Read More]

Peptoids Closely Resemble Human Proteins

Maxwell's peptoids are biomimetics, meaning they mimic naturally safe and effective antiviral peptides. Maxwell's peptoids have side chains attached at the nitrogen, instead of carbon-based side chains. This makes our peptoids strongly resistant to the protease enzymes which many pathogens use to destroy carbon-based immune peptides. The additional strength in a peptoid's nitrogen bond allows peptoids to fight viruses longer and harder than any known natural peptide.

Antimicrobial Peptoid

A Novel Mechanism of Action

Maxwell's peptoids use an electrostatic mechanism of action that allow peptoids to be highly attracted to pathogens while avoiding human cells. Viruses and many other pathogens have a negative charge which attracts Maxwell's peptoids, which are positively charged. Healthy human cells are neutrally charged and don't attract our drugs.

Learn more about Maxwell's peptoid drug class, set to potentially change the way we treat viral infections.